טוען...
Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor
With the increasing prevalence of living-donor liver transplantation (LDLT), the possible increased recurrence rate of hepatocellular carcinoma (HCC) in LDLT recipients in comparison with deceased-donor liver transplantation (DDLT) recipients has become a matter of debate. The aim of this review is...
שמור ב:
| הוצא לאור ב: | Hepatobiliary Surg Nutr |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AME Publishing Company
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075829/ https://ncbi.nlm.nih.gov/pubmed/27826557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2016.08.03 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|